What could pharma’s shift towards prevention mean for therapeutics?
The Longevity Biotech Report 2026 tracks $30bn+ invested, 3,036 therapeutics and 781 companies shaping the market.
Access the report free. Link in the comment.
Sponsored by MuseCell Innovations.
